Back to Search
Start Over
Docetaxel rechallenge in patients with prostate cancer progressing under castration levels of testosterone (PPuCT): A single-center study
- Source :
- Journal of Clinical Oncology. 29:e15105-e15105
- Publication Year :
- 2011
- Publisher :
- American Society of Clinical Oncology (ASCO), 2011.
-
Abstract
- e15105 Background: Until recent developments in treatment of PPuCT (cabezitaxel, abiraterone) progressing after docetaxel, second line therapies were scarce. In our Hospital, Docetaxel as first lin...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
business.industry
organic chemicals
Testosterone (patch)
urologic and male genital diseases
medicine.disease
Single Center
Surgery
Prostate cancer
Abiraterone
chemistry.chemical_compound
Castration
Second line
chemistry
Docetaxel
Internal medicine
medicine
In patient
business
therapeutics
neoplasms
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 29
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........0d9f41fe819973c89a9a551e50dca5e1
- Full Text :
- https://doi.org/10.1200/jco.2011.29.15_suppl.e15105